Member Info for BoNidel

Just what we’ve all been waiting for.

More drilling to follow up but already some fantastic grades there.

For a small cap AIM explorer, I feel remarkably comfortable having Brian Hall steering the ship.

Honest, Diligent & Organised.

What a great opportunity this is!

Has just announced he’s standing down from OKYO, bad for tils or good? Does he need to give his full time to something for TILS??

Communication hasn’t been the best I do agree, but does anyone have any idea of the complexity and timescales involved with new authorisations and listings for publicly listed companies and indeed small businesses that are regulated by the relevant financial services bodies???

I would love to see Someone offer 10p a share to every holder that’s upset about Accustem timescale and give them the chance to exit now.

Everyone that’s slated the BOD will take their cash and clear off if it gets bought out, they won’t be writing to praise the BOD in that instance. I don’t expect they’ll have a lot to say if they do well out if it but are happy to slate them 24/7 the fact that it hasn’t been listed Sooner.

The BOD owe you NOTHING, Accustem was spun off but wasn’t sold when it was part of TILS!!!! You had your tils shares including the Accustem part of the business, just like milciclib, TLZS-501 & Foralumab.

For the sake of all that is holy please stop moaning about Accustem! I would love HL or other brokers to offer big players the chance to buy Accustem entitlements for those who wish to sell prior to listing.

Then would follow the conversation about how the rich get richer & poor little old me gets stuff (whilst selling their Accustem shares to make another payment on their BMW or having a new kitchen fitted because the neighbours had one).

I’m equally gutted about the slide in the SP as said before but it’s becoming a noticeable trend, the SP declines and then de-rampers arrive on the board and it slowly slides. Then you get the middle ground long term holders (apparently) which could even be a ploy to scare off short term investors (no offence if you’re genuine) as they think SP won’t move for 2 or 3 years and then flee. All of a sudden then the SP starts to rise again! I’m not a conspi****** but I am starting to wonder if some Posters on here are paid de-rampers/fake LTH designed to neg people out so they can short it…

With the MS trials news could drop at any time over the next few weeks/months as there’s nothing like this in the market, even if it’s only Mildly effective as it seems to have no toxicity!

Upcoming news -
FMAB phase 2b trials (could it be in conjunction JV with someone else?)
- Accustem listing - if it blows expectations out of the water then the value of tils will really fly as a speculative pharma company has delivered value to shareholders when they normally just suck money out.
- milciclib takanawa partnership, who will this be with?
- Chrohns..

Once it’s proved to be non-toxic and no-side effects then FMAB will potentially be stuck up the nose of anyone with an ailment in relation to it as there’s nothing to lose by trying!…

Do I wish I sold @ £2? Yes, as a matter of fact I do, who wouldn’t?

Do I think the SP is currently undervalued? Yes, probably

Could I do with the money short term to do other things with? Yes probably, but that’s the decision you make.

Best of luck all & as usu

It is frustrating to watch it drop every day but I have to remind myself that last time it was at 80p I held up to £2 & back down again and kept kicking myself for not buying more at this range! Now I kick myself for not selling…

BOD have Been pretty quiet without any substance really in the interviews but to be fair if they are looking at a buyout currently or have NDA’s then there’s not a lot they can say.

The most interesting thing will be what happens with Accustem. If there’s significant value there I wonder what GC will do with his shares? Will he liquidate his Accustem shares & buy back in to tils to give himself a bigger holding?

I know Altium capital are out now but they probably have entitlements to a hell of a lot of Accustem shares. Will they also cash in then use the proceeds to fill some of the shelved offering on the NAS? That shelved offering is at A price of 1.50. I think Dr Weiners options are also @ 150 a share?

Really disheartening at the moment but you have to look at facts. I think there’s been a lot of de-ramping on the board and some frustration (understandably) with the Accustem thing.

I think the BOD might just surprise us.

Also, if Accustem is worth a chunk or gets taken over then the tils SP will probably rocket as they will have delivered real value to shareholders.

If you can find a share where the value isn’t already realised but the results are proven & thus aren’t investing in wishful thinking then please let us know.

I think what’s being overlooked is what the next covid trial includes. Last one included dexamethasone.

Perhaps hinted at by Dr Weiner yesterday was the

If you can find a share where the value isn’t already realised but the results are proven & thus aren’t investing in wishful thinking then please let us know.

I think what’s being overlooked is what the next covid trial includes. Last one included dexamethasone.

Perhaps hinted at by Dr Weiner yesterday was the

If you can find a share where the value isn’t already realised but the results are proven & thus aren’t investing in wishful thinking then please let us know.

I think what’s being overlooked is what the next covid trial includes. Last one included dexamethasone.

It was again pointed out by Dr Weiner that the non-toxicity of this & other nasally/orally administered antibodies is what is so exciting.

Perhaps this is a pre-cursor to big pharma wanting to participate in one of the trials given the safety profile & delivery method.

Probably the first month in a few years that TILS hasn’t RNS after having a look at the history.

Either this is genuinely back in first gear or something fairly chunky is due.

Strange either way.

Not bothered about accustem really. It’s frustrating but these things take time.

Who knows what’s going on in the background...

What you say is just so contradictory.

So you want a weak economy but strong share prices?

I could have sold out two (or is it three now?) times at 180+ for a bag and more profit.

Am I annoyed right now, yes. But Im so sick of reading comments from butthurt losers on here that just want RNS to come out to bolster the share price so they can double their £250 quid investment and pay the PCP on their BMW for another month.

Am I due accustem shares? Yes.

Am I thinking about it every day? No. This BS from people has just got to stop. The phone in call questions to Dr Kunwar made me wince, we don’t even know what the value is for Accustem yet and people are still just being absolutely babies over it.

I hope that even if there’s a solid offer for accustem at great money that they list it instead & then tell everyone how much they’ve missed out on just so some of you absolute little spoilt brat babies can learn your lesson.

I have a pretty sensible 5 figure investment in tils, it was a lot of profit for me recently when I could (and maybe should) have sold but if you’re not willing to lose money just don’t invest. Go and put some decking on your house or something and pretend you’re making money, or better still, do some overtime at work.

FFS stop moaning about accustem, stop moaning about the SP as you sell out. The little sells of 50 and 100 shares on here are just tragic.

If you want to talk about something then why don’t you forensically exam everything that’s going on with tils at the moment & then try to piece things together to see if your investment here is more or less likely to come to fruition.

There’s loads of things I’ve picked up on this last week or two which could be massively significant or alternatively just coincidence. I’m not even going to share them here any more as it’s Just a BS forum at the moment.

I come here everyday to see if there’s info about tils or some good news and just get absolutely soft little babies moaning they’ve lost a few quid.

Grow up

It is now. Was 15%. Large spike regardless.

By pure odds this has to see a few blue days soon, surely.

Something strange happening on the Nasdaq, 15.7% up after hours

Gutted here, I thought 125-150 was the benchmark. The covid news was good but I think the BOD are just too slow in everything they do and constantly miss deadlines. The accustem thing is an example of this, I don’t really care either way as it is a bonus but there’s just total radio silence. Would have to eat humble pie though if they were selling it etc.

With the current SP, every day I think I should probably sell now. What’s it now? 3 weeks of constantly dropping?

I think they are just too slow to market with the covid play and possibly this is overvalued in its current guise as until they have everything, they have nothing.

I haven’t noticed any director deals recently & no RNS since the start of the month.

My fear isn’t in that they aren’t sending out RNS to keep the price up, more so that they genuinely have no news to share, nothing new happening...

I hope I’m proved to be wrong but this has turned into a bit of a dog lately!

Twice I’ve held up to 180/190 and back down again. How low can it go?...

Topped up again today. Back at the price I Bought a fair lump of. Not sure if that was a good or bad decision looking at the way it’s going currently.

One thing I do hope, however, is that if I do have to exit this share for some reason that is unplanned is that it still FLIES up and shafts anyone shorting, or more so, the jump-shippers that are causing the instability. Why the hell would anyone buy a share like this that wasn’t waiting for bigger things.

Ridiculous.

Hope it recovers to a price around 145-150 and I’m happy to leave it there.

That being said, who knows what news is in the pipeline...

Hadn’t seen that. Using words like “phenomenal” really are promising!

Really wondered why the SP didn’t react massively to this news, perhaps it was priced. Either that, or the market is missing a trick.

One thing I have wondered is that as FMAB appears to be totally non-toxic, could they increase the dosage and yield even better results!?

Must be a hell of a lot of behind the scenes work going on at the moment, really looking forward to upcoming RNS. This feels like blue chip in the making but aside from financial benefits of being an investor, it’s really enthralling to have taken and interest in this and actually see the results come to life!

I (like everyone else - apart from from short positions) would love to see the SP rise but the business seems pretty stable currently with a lot of support around the 140-150 range.

Maybe it’s found it’s new level...

Phase 3 trials, FDA emergency use, joint venture or sale could see this spike ridiculously but I would genuinely find it rewarding to see FMAB being used as a product to treat CV-19 and indeed other conditions

I’ve only been invested in TILS for probably 2 years (ish?) but they’ve been pushing a massive Boulder uphill for that period and many years before that.

Hopefully we are reaching a downhill stretch now where the going is easy and they can really pick up some momentum.

3 biggest factors for me are;

- management capability
- technology
- potential to disrupt big Pharma

I too have been frustrated about missed deadlines, but we must consider the behind the scenes work which is going on. This could be a hugely news rich period over the next month & we will probably look back in hindsight and say it was obvious! I was in way before 80p levels, top sliced when it was around £2, bought back in for accustem then held back down. I then topped up again and again & then increased my holding by over 100% @ 132. Yes there could be slow periods, but for me, this wasn’t a share I wanted to be out of.

I could have taken a fat profit @ 190p recently but the thought of being out when huge news dropped was what kept me in.

Perhaps greedy, but this really could be a huge value company.

Looking at some of the companies that have bagged 10x+ in the past, you think “I wish I was in on that”, but then to be part of the huge gains you have to hold onto your profits and be willing to ride peaks and troughs!

Nothing wrong with a top slice or similar, but if you want the real growth you have to hold as many shares as possible.

Huge piles of work to do this evening but wishing everyone well next week with potentially groundbreaking news due.

Hopefully we can develop a bit of support for this business to see it through to further clinical trials.

I believe GC said before the Brazil trials that this would serve as a pre-Cursor or stage 3 trials or emergency FDA approval.

Remember, the effectiveness is not necessarily the be all and end all. The delivery method and potential Nil toxicity is as important as the results itself!

The dexamethasone /fmab results will serve to prove that this delivery Technology & FMAB itself can be paired with potentially anything else on the market!

GC said that the FMAB was to reduce the cytokines storm & the dex was to combat the virus.

Feel like I’m ramping now but this really could be groundbreaking and life changing for millions of people around the world.

I’m personally happy for the share price to slide if it means that some of the less fortunate in the world can get access to potentially life saving treatment at a minimal cost.

Good luck all and as usual, all opinions not advice.

Try and get some sleep tonight!...

Noticed in October they also took on an IR/BD manager.

Perhaps I’m shooting from the hip here but what need would there be for a business development & investor relations manager for a business that is not near a product yet?

So many coincidental factors with TILS at the moment really do make you wonder if we are at a pivotal moment.

If you were looking back in hindsight, you’d say that the trials, Dr Graham appointment, fund raise & all the other stuff would have made it obvious that something big was coming!

That being said who knows if this is just all inconsequential...

Will the delivery method and totally non-toxicity of FMAB be what others are gearing up to purchase?

Really wish I had X-ray glasses with this one. To the point where its not about the money, just exciting to know what’s on the horizon and if your assumptions were right!

Maybe some totally unexpected RNS on the cards. Who knows...

Monday could be an interesting day!

GLA DYOR Opinions - not advice

Although disappointing to see drops, that is unfortunately the nature of the beast. Steady gains get destabilised by huge jumps, usually originating on the NASDAQ.

Seems to be a totally different attitude to shares over the other side of the pond.

They are, however, important for liquidity and progressing things further.

Obviously everyone wants to see their shares increase in value but with current happenings over there this is to be expected. Probably shows you the percentage of pure gamblers in TLSA.

Doesn’t seem like we are dying a death here but the nas will probably open and fly up again which is what we DONT want.

Long term fairly stagnant share prices with incremental gains relating to development of their tech is what is optimal for TILS.

Going to bottom drawer this one for the day.

Would be interesting to see if they stick to the EOM deadline for the trial results though. I think genuine holders here are itching to see the results just to see if FMAB is going to carry on its developments. Covid is skewing this one...

GLA

Maybe 1 of the following;

- Joint Venture
- Merger
- II Wants to purchase a fair whack
- Money needed to fast-track FMAB through phase 3
- Emergency Issue as a result of incredible results?

Don’t want to ramp as was worried first but if they are raising $250,000,000 then there must be a fantastic reason.

Failing that if they aren’t raising but are leaving headroom there’s got to be another reason! 6 hours from now, we may well know!

May well have turned.

Do I doubt this share? Of course I do. Any investor that tells you’re they’re 100% confident in their decision is either lying to you, or worse, to themselves.

The overall profile & pipeline of TILS is impressive to say the least. Notwithstanding this, you still have to be objective when considering if this is a good investment.

There are pro’s and cons to all current factors which are worth considering.

Do they have some fantastic groundbreaking technologies? Yes, of course they do. That being said, why haven’t they received any solid offers yet if the technologies are that great and indeed, likely to be disrupters to the rest of the MAB industry?

Is the cash position good? Yes, phenomenal at £62m (or whatever the good doctor said) against MCAP, then again, at a burn rate of £32m budget this year & £28m next year, it’s not going to last long. Clinical trials, R&D and other various other expenditures cost a fortune in this industry.

They are spending $10,000+ a month just on redchip by the looks of things. A lot of money for a business that doesn’t produce any revenue yet.

If the covid results are that promising, surely we would know more by now? Will the results be underwhelming or insubstantial?

Who knows is the honest answer.

To look at things from a different perspective though, the current board (including the recent appointment) seem to have a great background and a good grasp of the current situation, and indeed, the plan ahead.

If just 1 of these technologies does come to fruition, the ROI based on current share prices will be exponential.

You could say that currently, the MCAP and SP just looks too good to be true based on the pipeline and progress in trials so far.

If the Dr is right about Aim companies being worth 50/60% less than main market businesses, then we are potentially at the right money (or slightly less than we should be).

If accustem is worth £2 a share then great, we’ve had fantastic value out of TILS & it proves what a great buy it was even at this stage. It also proves the ability for the BOD to commercialise opportunities. Conversely, you could argue that a lot of the value has gone from TILS if the Accustem price is strong.

If accustem is 10p a share, then based off current price, we still have value & potentially proved that TILS was where the real value was.

It’s very hard to really call it.

Either way, I think long term holders will probably be safe on this share.

I will reiterate my position on the upcoming data though. How can you possibly be out when potentially pivotal results are about to be released that could send the SP into orbit?

If FMAB is successful, it will be going through expedited further trials & could see a JV with one of the big boys.

One thing is certain thought, we will soon see, that’s for sure..

These are all my own opinions and not intended to be investment advice.

GLA